| Celgene Corporation | 108.28 |
| Date/Time | 11/20 / 21:59 |
| Chg. / Chg.(%) | - / |
| Bid | 108.15 / 33 |
| Ask | 109.50 / 2 |
| Open | 107.90 |
| Previous Close | 108.20 |
| High | 108.58 |
| Low | 107.28 |
| Volume [USD] | 393,221,131.68 |
| Volume [Units] | 4,250,731 |
| Price fixings | 29459 |
| ISIN | US1510201049 |
| Security | CELG |
| Exchange | Cboe US |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 93.00 |  |
|
| SIX Swiss Ex.. | 89.40 | |
|
| NASDAQ | 108.2400 | 191,230,586 | |
| Cboe US | 108.28 | 4,250,731 | |
| IEX | 108.30 | 1,222,357 | |
| London Inter.. | 107.94 | 826,453 | |
| Stuttgart | 97.500 | 563 | |
| Mexico | 2,099.33 | 532 | |
| gettex | 97.400 | 110 | |
| Lang & Schwa.. | 97.370 |
News
- Jounce Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020
19:25 - GlobeNewswire - Yield10 Bioscience Appoints Agriculture Industry Veteran Sherri M. Brown, Ph.D., to Board of Directors
02/13/2020 / 14:30 - GlobeNewswire - Aprea Therapeutics Appoints Gregory S. Wessels as Vice President, Commercial
02/13/2020 / 14:00 - GlobeNewswire - Agios Reports Fourth Quarter and Full Year 2019 Financial Results
02/13/2020 / 13:00 - GlobeNewswire - PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
01/27/2020 / 15:00 - GlobeNewswire
Real-time